Global Psychobiotics Markets Analysis & Forecasts, 2016-2020 & 2021-2026
Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Psychobiotics Market, By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula), By Psychotropic Agent, By Form, By Distribution Channel, By Application, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.
The growth of Global psychobiotics market in the forecast period, 2022-2026 can be attributed to the rising demand of the probiotics for the psychological ailments like depression and anxiety.
Additionally, rising instances of depression and anxiety among the population at large is driving the growth of the global psychobiotics market in the next five years.
Moreover, the number of consumers concerned about mental health as well as physical health is rapidly increasing. The consumers are concerned about the over the counter available psychobiotics drugs that may or may not cause adverse effects on the consumers' physical health.
Mental illness is also rapidly affecting the population, especially the young population. Health conscious and woke population is actively utilizing the availability of these psychobiotics and incorporating them in their daily food routines, thereby supporting the growth of the global psychobiotics market in the upcoming five years.
Nutritional supplements are anticipated to hold the largest revenue shares of the market and assert its dominance over the market on the account of rapidly growing number of consumers inclined toward self-medication. The consumers are eagerly adapting the psychobiotics as a nutritional supplement for healthy brain.
Large population is suffering from depression, stress and anxiety. The tendency of self-diagnosing and self-medication is very active among the young population and thus they are aiding to the growth of the global psychobiotics market in the upcoming five years forecast, until 2026.
Competitive Landscape
Market players are actively involved in the research and technological development in the medical device and testing kit developments. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through psychobiotics.
Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Holding the major shares of the global psychobiotics market are
InnovixLabs
Bened Biomedical Co., Ltd
Nutrimmun GmbH
Kerry Group Plc.
Sabinsa Corporation
Lallemand Health Solutions Inc.
DuPont de Nemours, Inc.
Uplift Food Pty Ltd.
Nature's Bounty Co. Ltd.
BioGaia Group
The Life Extension Foundation
Lifted Naturals
Report Scope:
Years considered for this report:
Historical Years: 2016 - 2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022 - 2026
Global Psychobiotics Market, By Type:
Food Supplements
Nutritional Supplements
Specialty Nutrients
Infant Formula
Global Psychobiotics Market, By Psychotropic Agents:
Streptococcus
Bifidobacterium
Lactobacillus
Clostridium
Others
Global Psychobiotics Market, By Form:
Powder
Liquid/ Fluid
Tablets
Global Psychobiotics Market, By Distribution Channel:
Retail Shops
Hypermarkets/ Supermarkets
Drug Store/ Pharmacy
Online
Global Psychobiotics Market, By Application:
Gastrointestinal Function
Antidepressant
Anxiolytic
Autism Spectrum Disorder
Attention Deficit Hyperactivity Disorder
Schizophrenia
Others
Global Psychobiotics Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Slovakia
Poland
Sweden
Asia-Pacific
China
Japan
India
South Korea
Australia
Singapore
Malaysia
Taiwan
Middle East & Africa
South Africa
Saudi Arabia
UAE
South America
Brazil
Argentina
Colombia
For more information about this report visit https://www.researchandmarkets.com/r/rlyhzw
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900